drugset / Trial / NCT02606773
"Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the bioavailability of "Novo C Plus" vitamin C containing dietary supplement compared to licensed vitamin C medications. The novelty of this product is the liposomal formulation.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 500 mg | Intravenous |
| Subject | Vitamin C | Other / unclassified | 600 mg | Intravenous |
| Subject | Vitamin C | Other / unclassified | 900 mg | Intravenous |